A bright future Looking to the future Biotech company Novoheart has created the world’s first miniature artificial heart using stem cells, with the aim of offering pharmaceutical testing methods which are more efficient than animal testing and clinical trials. The new device is a tiny version of an adult heart, made from human embryonic stem cells. The device replicates one of the human heart’s four chambers but does not need a blood supply. At the same time, its MyHeart platform offers technology to help researchers understand the impact different drugs have on the human heart. Novoheart is planning further research.
Biotech company Novoheart has created the world’s first miniature artificial heart using stem cells, with the aim of offering pharmaceutical testing methods which are more efficient than animal testing and clinical trials. The new device is a tiny version of an adult heart, made from human embryonic stem cells. The device replicates one of the human heart’s four chambers but does not need a blood supply. At the same time, its MyHeart platform offers technology to help researchers understand the impact different drugs have on the human heart. Novoheart is planning further research.